Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. was founded in 2006 and is based in Buffalo, New York.
Metrics to compare | AIFF | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipAIFFPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.7x | −0.9x | −0.5x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | 7.5x | 0.6x | 2.6x | |
Price / LTM Sales | 280.1x | 1.3x | 2.9x | |
Upside (Analyst Target) | - | 33.8% | 45.8% | |
Fair Value Upside | Unlock | 32.2% | 8.6% | Unlock |